Shares of ETHZilla (ETHZ), formerly known as biotech firm 180 Life Science, fell nearly 30% Friday after the company disclosed that shareholders filed to offer up to 74.8 million convertible shares.
The offering sparked concerns about dilution, a process where existing shareholders’ stakes lose…
